Bacteriological differences between COPD exacerbation and community-acquired pneumonia

Respiratory Care

Volumn 56, Issue 11, 2011, Pages 1818-1824

  Li, Xue Jun ^a   Qi, Li ^a   Si, Liang Yi ^a   Yuan, Qiao Ying ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bacteriology; Community acquired pneumonia; COPD; Exacerbation

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM; CEPHALOSPORIN; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; ESCHERICHIA COLI; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PSEUDOMONAS AERUGINOSA; SPECIES DIFFERENCE; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DISEASE PROGRESSION; FEMALE; HUMANS; LENGTH OF STAY; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; SPUTUM;

EID: 82455186241     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.00915     Document Type: Article

References (25)

1. Chinese Center for Disease Control and Prevention. Report of chronic diseases in China 2006.
2. Diaz A, Barria P, Niederman M, Restrepo M, Dreyse J, Fuentes G, et al. Etiology of community-acquired pneumonia in hospitalized patients in Chile: the increasing prevalence of respiratory viruses among classic pathogens. Chest 2007;131(3):779-787.
3. Ko FW, Ng TK, Li TS, Fok JP, Chan MC, Wu AK, Hui DS. Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong. Respir Med 2005;99(4):454-460.
4. Mette V, Julie H, Susanne D, Alice F, Thomas R, Peter L. Bacteriology in acute exacerbation of chronic obstructive pulmonary disease in patients admitted to hospital. Scand J Infect Dis 2009;41(5): 26-32.
5. Fanny W, Margaret I, Paul K, Susanna S, Chau S, David S. A one-year prospective study of infectious etiology in patients hospitalized with acute exacerbations of COPD and concomitant pneumonia. Respir Med 2008;102(8):1109-1116.
6. Molions L, Clemente M, Miranda B, Alvarez C, Busto B, Cocina B, et al. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease. J Infect 2009;58(4):417-424.
7. Restrepo M, Mortensen E, Pugh J, Anzueto A. COPD is associated with increased mortality in patients with community-aquired pneumonia. Eur Respir J 2006;28(1):346-351.
8. Fang G, Fine M, Orioff J, Arisumi D, Yu V, Kapoor W, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. Medicine 1990;69(13):307-316.
9. Infectious Diseases Society of America/American Thoracic Society Consensus. Guidelines on the management of adults with community acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl): S27-S72.
10. Falguera M, Martin M, Ruiz-Gonzale A, Pifarre R, Garcia M. Community-acquired pneumonia as the initial manifestation of serious underline diseases. Am J Med 2005;118(23):378-383.
11. Torres A, Menendez R. Mortality in COPD patients with community-acquired pneumonia: who is the third partner? Eur Respir J 2006;28(4):262-263.
12. Rello J, Rodriguez A, Torres A, Roig J, Sole V, Garnacho M, et al. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J 2006;27(5): 1210-1216.
13. Patel I, Seemungal T, Wilks M, Lloyd O, Donaldson G, Wedzicha J. Relationship between bacterial colonization and the frequency, character, and severity of COPD exacerbations. Thorax 2002;57(9): 759-764.
14. Ricard P, Miquel F, Carmina V, Antonio N. Characteristics of community- acquired pneumonia in patients with chronic obstructive pulmonary disease. Respir Med 2007;101(10):2139-2144.
15. Groenwegen K, Wouters E. Bacterial infections in patients requiring admission for an acute exacerbation of COPD. Respir Med 2003; 97(15):770-777.
16. Marrie T, Shariatzadeh M. Community-acquired pneumonia requiring admission to an intensive care unit. Medicine 2007;86(8):103-111.
17. Lim W, Lewis S, Macfarlane J. Severity prediction rules in community- acquired pneumonia: a validation study. Thorax 2000;55(7): 219-223.
18. Richard D, Robert P, Sydney M. Amikacin therapy for gramnegative septicemia. The Am J Med 1997;62(6):930-935.
19. Qiu Junfeng, Huang Kunrong, Wu Qian. Analysis of the monitorin resistance data of E. coli in recent three years. J Chongqing Medical Univer 2007;32(2):173-175.
20. Mu Xuekun, Chen Shengwen, Wang Shayan, Fu Yingyun, Lu Yuemei, Zhang Ruanzhang. Resistance and genetic testing on the ESBLs produced by Escherichia coli and Klebsiella pneumoniae. Chin J Infect Chemoth 2006;13(5):301-305.
21. Ernst P, Gonzalez AV, Brassard P, Sussa S. Inhaled corticosteroid use in COPD and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med 2007;176(2):162-166.
22. Ernst P, Gonzalez AV, Brassard P, Suissa S. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med 2007;176(2): 111-112.
23. Ko FW, Lam RK, Li TS, Fok JP, Chan MC, Ng TK, et al. Sputum bacteriology in patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease and concomitant pneumonia in Hong Kong. Intern Med J 2005;35(11):661-667.
24. Woodhead M, Blasi F, Ewig S. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005;26(8): 1138-1180.
25. Miyashita N, Matsushima T, Oka M. The ERS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendation. Inter Med 2006;419-426.